短期药物对多病性痴呆症住院患者跌倒风险的影响
Franziska Podesser1, Johannes Weninger2, Elisabeth M Weiss1
1Department of Psychology, University of Innsbruck, Innsbruck, Austria.
Gerontology
|April 16, 2024
概括
高剂量的抗精神病药物和抗胆固醇负担增加了痴呆症患者的风险. 停药也会增加在跌倒前48小时内跌倒的发生率.
科学领域:
- 老年学是一门学科.
- 临床药房 临床药房
- 神经学 神经学
背景情况:
- 痴呆症患者面临更多的跌倒和受伤风险,可能与药物使用有关.
- 有限的证据表明,特定的药物有助于这一群体的下降.
研究的目的:
- 研究住院痴呆症患者的药物使用,药物变化和跌倒风险之间的关联.
- 识别特定的药物和与药物相关的因素,增加短期跌倒风险.
主要方法:
- 一项匹配的病例控制研究,涉及74名住院痴呆症患者.
- 分析电子医疗记录,检查药物详细信息,诊断和跌倒事件发生在跌倒前48小时内.
- 双项逻辑回归用于评估各种药物参数的影响,包括抗精神病剂量,抗胆固醇负担和停药.
主要成果:
- 在跌倒前24小时内增加每日抗精神病剂量与较高的跌倒率显著相关.
- 较高的抗胆固醇负担和在跌倒前24-48小时间停止服用药物也与跌倒发生率的增加相关.
- 药物和精神药物的总数没有显著影响跌倒发生率.
结论:
- 痴呆症患者的短期跌倒风险受到高抗精神病剂量,抗胆固醇负担和药物停用的影响.
- 临床注意力应集中在这些因素上,以减轻跌倒风险.
- 建议使用更大的样本大小进行进一步的研究,以验证这些发现.
更多相关视频
04:13Using a Real-Time Locating System to Measure Walking Activity Associated with Wandering Behaviors Among Institutionalized Older Adults
Published on: February 8, 2019
6.8K
05:26Author Spotlight: Innovations in iTUG Test for Enhanced Risk Assessment and Cognitive Insights
Published on: October 25, 2024
1.0K
相关概念视频
Drug Therapy
43
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
43
Psychosis: Goals of Pharmacotherapy
124
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
124
Alzheimer's Disease: Treatment
183
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
183
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
61
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
61
Parkinson's Disease: Treatment
264
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
264
Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
